2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Intramucosal Cancer
Intramucosal cancer refers to cancerous cells found within the mucosal layer of an organ or tissue, typically detected early in its development. This type of cancer is often localized and has not yet spread beyond the mucosal layer, making it potentially treatable with less invasive interventions like endoscopic resection. Researchers in cancer science are actively studying intramucosal cancer to understand its progression mechanisms, risk factors, and optimal treatment strategies. Advances in imaging techniques and molecular analysis have enhanced early detection capabilities, improving patient outcomes. Furthermore, investigating the molecular signatures of intramucosal cancer cells holds promise for personalized treatment approaches, aiming to minimize side effects and maximize therapeutic efficacy. By unraveling the intricacies of intramucosal cancer biology, researchers aim to develop more precise diagnostic tools and targeted therapies, ultimately improving the prognosis for affected individuals.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China